Rochelle R Smits-Seemann1,2, Sapna Kaul3, Eduardo R Zamora4, Yelena P Wu5,6, Anne C Kirchhoff7,5. 1. Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Utah, Salt Lake City, UT, USA. Rochelle.smits@hci.utah.edu. 2. Cancer Control and Population Sciences, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Rm 4124, Salt Lake City, UT, 84112, USA. Rochelle.smits@hci.utah.edu. 3. Department of Preventive Medicine and Community Health, University of Texas Medical Branch, Galveston, TX, USA. 4. Utah Department of Health, Salt Lake City, UT, USA. 5. Cancer Control and Population Sciences, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Rm 4124, Salt Lake City, UT, 84112, USA. 6. Department of Family and Preventive Medicine, University of Utah, Salt Lake City, UT, USA. 7. Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Utah, Salt Lake City, UT, USA.
Abstract
PURPOSE: Though the need for risk-based follow-up care for survivors of adolescent and young adult (AYA) cancer has been documented, survivors often report forgoing recommended care due to cost. We sought to understand whether additional barriers to follow-up care exist for AYA survivors. METHODS: We recruited survivors who were diagnosed with cancer between the ages of 15 and 39 using the Utah Cancer Registry (UCR). Overall, 28 survivors participated in 6 focus groups held between March and May 2015 in Salt Lake City and St. George, UT. Focus group discussions focused on the reasons survivors may or may not attend recommended medical visits after completing therapy. RESULTS: Survivors reported myriad barriers to follow-up medical visits, including lack of clear provider recommendation, fear of recurrent cancer diagnosis, wishing to move on with life, competing life responsibilities due to work and children, and not perceiving the need for a visit due to lack of symptoms. CONCLUSIONS: Though cost likely plays a major part in follow-up care adherence for survivors of AYA cancer, in our focus groups, participants indicated there were many other psychosocial and logistic barriers to care. Such factors play an important role in the day-to-day lives of survivors and are critical in medical decision-making. IMPLICATIONS FOR CANCER SURVIVORS: Several factors impede follow-up care adherence for survivors of AYA cancer that are amenable to interventions, including clearer provider recommendations, flexible appointment times, and childcare availability in clinics.
PURPOSE: Though the need for risk-based follow-up care for survivors of adolescent and young adult (AYA) cancer has been documented, survivors often report forgoing recommended care due to cost. We sought to understand whether additional barriers to follow-up care exist for AYA survivors. METHODS: We recruited survivors who were diagnosed with cancer between the ages of 15 and 39 using the Utah Cancer Registry (UCR). Overall, 28 survivors participated in 6 focus groups held between March and May 2015 in Salt Lake City and St. George, UT. Focus group discussions focused on the reasons survivors may or may not attend recommended medical visits after completing therapy. RESULTS: Survivors reported myriad barriers to follow-up medical visits, including lack of clear provider recommendation, fear of recurrent cancer diagnosis, wishing to move on with life, competing life responsibilities due to work and children, and not perceiving the need for a visit due to lack of symptoms. CONCLUSIONS: Though cost likely plays a major part in follow-up care adherence for survivors of AYA cancer, in our focus groups, participants indicated there were many other psychosocial and logistic barriers to care. Such factors play an important role in the day-to-day lives of survivors and are critical in medical decision-making. IMPLICATIONS FOR CANCER SURVIVORS: Several factors impede follow-up care adherence for survivors of AYA cancer that are amenable to interventions, including clearer provider recommendations, flexible appointment times, and childcare availability in clinics.
Entities:
Keywords:
AYA cancer; Barriers to care; Risk-based follow-up care; Survivorship
Authors: Rochelle R Smits-Seemann; Jaehee Yi; Tian Tian; Echo L Warner; Anne C Kirchhoff Journal: J Adolesc Young Adult Oncol Date: 2016-07-15 Impact factor: 2.223
Authors: Sapna Kaul; Mark Fluchel; Holly Spraker-Perlman; Christopher F Parmeter; Anne C Kirchhoff Journal: Support Care Cancer Date: 2016-04-28 Impact factor: 3.603
Authors: Theresa H M Keegan; Daphne Y Lichtensztajn; Ikuko Kato; Erin E Kent; Xiao-Cheng Wu; Michelle M West; Ann S Hamilton; Brad Zebrack; Keith M Bellizzi; Ashley W Smith Journal: J Cancer Surviv Date: 2012-03-29 Impact factor: 4.442
Authors: Kevin C Oeffinger; Ann C Mertens; Charles A Sklar; Toana Kawashima; Melissa M Hudson; Anna T Meadows; Debra L Friedman; Neyssa Marina; Wendy Hobbie; Nina S Kadan-Lottick; Cindy L Schwartz; Wendy Leisenring; Leslie L Robison Journal: N Engl J Med Date: 2006-10-12 Impact factor: 176.079
Authors: Judy Y Ou; Rochelle R Smits-Seemann; Yelena P Wu; Jennifer Wright; Anne C Kirchhoff Journal: J Cancer Surviv Date: 2017-11-29 Impact factor: 4.442
Authors: Sarah Nicole Hamilton; Omair Arshad; Jaime Kwok; Eric Tran; A Fuchsia Howard; Isabel Serrano; Karen Goddard Journal: Support Care Cancer Date: 2018-11-22 Impact factor: 3.603
Authors: Samantha T Pannier; Echo L Warner; Brynn Fowler; Douglas Fair; Sara K Salmon; Anne C Kirchhoff Journal: J Cancer Educ Date: 2019-04 Impact factor: 2.037
Authors: Joemy M Ramsay; Karely Mann; Sapna Kaul; Eduardo R Zamora; Rochelle R Smits-Seemann; Anne C Kirchhoff Journal: J Adolesc Young Adult Oncol Date: 2018-01-18 Impact factor: 2.223
Authors: Jacqueline N Casillas; Lindsay F Schwartz; Catherine M Crespi; Patricia A Ganz; Katherine L Kahn; Margaret L Stuber; Roshan Bastani; Faisal Alquaddomi; Deborah L Estrin Journal: J Cancer Surviv Date: 2019-07-26 Impact factor: 4.442
Authors: Poornima Saha; Meredith M Regan; Olivia Pagani; Prudence A Francis; Barbara A Walley; Karin Ribi; Jürg Bernhard; Weixiu Luo; Henry L Gómez; Harold J Burstein; Vani Parmar; Roberto Torres; Josephine Stewart; Meritxell Bellet; Antonia Perelló; Faysal Dane; Antonio Moreira; Daniel Vorobiof; Michelle Nottage; Karen N Price; Alan S Coates; Aron Goldhirsch; Richard D Gelber; Marco Colleoni; Gini F Fleming Journal: J Clin Oncol Date: 2017-06-27 Impact factor: 44.544
Authors: Anne C Kirchhoff; Brynn Fowler; Echo L Warner; Samantha T Pannier; Douglas Fair; Holly Spraker-Perlman; Jeff Yancey; Brad Bott; Carolyn Reynolds; R Lor Randall Journal: J Adolesc Young Adult Oncol Date: 2017-06-12 Impact factor: 2.223
Authors: Morgan M Millar; Anita Y Kinney; Nicola J Camp; Lisa A Cannon-Albright; Mia Hashibe; David F Penson; Anne C Kirchhoff; Deborah W Neklason; Alicia W Gilsenan; Gretchen S Dieck; Antoinette M Stroup; Sandra L Edwards; Carrie Bateman; Marjorie E Carter; Carol Sweeney Journal: Am J Epidemiol Date: 2019-05-01 Impact factor: 4.897